Helical tomotherapy treatment of dominant intraprostatic lesions in patients with prostate carcinoma utilizing magnetic resonance imaging and spectroscopic guidance

This study will utilize tomotherapy to increase radiation dose delivered to magnetic resonance imaging and spectroscopy targeted dominant intraprostatic lesions in patients with prostate adenocarcinoma.

You may be eligible to participate in this study if you:

• Are a patient with intermediate to high risk adenocarcinoma of the prostate requiring treatment to the whole pelvis and prostate
• Are a patient with 1-2 dominant intraprostatic lesions as evidenced by MRI/MRS in one lobe of the prostate who are candidates for treatment with external beam radiotherapy
• Are a patient who have no DILs,>2 DILs, or DILs in both lobes will be excluded from this study

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via e-mail, please include the title of the study in your message.